Evidence map›Paper›PMID 29126915›Full record

ArticlePreventive medicine2018

Steps, moderate-to-vigorous physical activity, and cardiometabolic profiles.

Samantha Hajna, Nancy A Ross, Kaberi Dasgupta

Abstract read
In one paragraph

Article in Preventive medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Ten things to know about ten cardiovascular disease risk factors - 2022.American journal of preventive cardiology · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samantha HajnaMRC Epidemiology Unit, Institute of Metabolic Sciences, University of Cambridge, Cambridge, UK; Department of Geography, McGill University, Montréal, Quebec, Canada.
Nancy A RossDepartment of Geography, McGill University, Montréal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada.
Kaberi DasguptaDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada; Department of Medicine, Division of Internal Medicine, McGill University Health Centre, Montréal, Quebec, Canada; Department of Medicine, Division of Clinical Epidemiology, McGill University Health Centre, Montréal, Quebec, Canada; Department of Medicine, Division of Endocrinology and Metabolism, McGill University Health Centre, Montréal, Quebec, Canada. Electronic address: kaberi.dasgupta@mcgill.ca.

Funding

CIHR FRN 146766Medical Research Council MC_UU_12015/4
6 · The paper itself

Abstract

The relative benefits of meeting the current moderate-to-vigorous intensity physical activity (MVPA) and active step count recommendations are unknown. Using robust linear regressions, we compared cardiometabolic marker differences (blood pressure, lipid levels, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), hemoglobin A1C, C-reactive protein (CRP), and body mass index (BMI)) across MVPA (150min/week) and step (10,000 steps/day) thresholds and between step categories (low active: 5000 to 7499, somewhat active: 7500 to 9999, and active: ≥10,000 steps/day vs. inactive: <5000 steps/day) in approximately 6000 Canadian adults (41.5years, SD 14.9). Differences across MVPA and step thresholds were similar but additional benefits were observed for BMI and A1C for the MVPA target (i.e., above vs. below 150min/week MVPA: -1.02kg/m

Indexed as

WalkingAdultBlood PressureBody Mass IndexCanadaCardiovascular DiseasesC-Reactive ProteinExerciseFemaleGlycated HemoglobinHumansMaleSurveys and QuestionnairesTriglyceridesC-Reactive ProteinGlycated HemoglobinTriglyceridesAccelerometerBlood pressureBMIEpidemiologyRisk factors

Identifiers

PMID29126915
PMCPMC6625960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.